Subtopic Deep Dive
Myositis-Specific Autoantibodies
Research Guide
What is Myositis-Specific Autoantibodies?
Myositis-specific autoantibodies (MSAs) are autoantibodies targeting unique nuclear, cytoplasmic, or cell surface antigens in idiopathic inflammatory myopathies, enabling precise disease classification and prognosis.
MSAs include anti-Mi-2, anti-Jo-1, anti-TIF1-γ, anti-PM/Scl, and anti-Ku, each associating with distinct clinical phenotypes like interstitial lung disease or skin involvement. Betteridge and McHugh (2015) reviewed their diagnostic utility across 1019 citations. Approximately 10 key MSAs are identified in over 60% of myositis patients.
Why It Matters
MSAs stratify heterogeneous inflammatory myopathies for personalized treatment, with anti-Jo-1 marking 68% of myositis cases with interstitial lung disease (Bernstein et al., 1984, 549 citations). Mariampillai et al. (2018) proposed a classification system using MSAs defining antisynthetase syndrome and other subgroups (418 citations). Betteridge and McHugh (2015) showed MSAs guide diagnosis when muscle biopsy is inconclusive, improving outcomes in dermatomyositis and polymyositis.
Key Research Challenges
Heterogeneous MSA Profiles
MSAs vary by ethnicity and overlap syndromes, complicating classification (Love et al., 1991, 969 citations). Ghirardello et al. (2013) noted inconsistent detection in polymyositis-dermatomyositis (461 citations). Standardization across labs remains unresolved.
Prognostic Value Uncertainty
Linking specific MSAs like anti-TIF1-γ to cancer risk needs longitudinal data (Lundberg et al., 2021, 596 citations). Bernstein et al. (1984) associated anti-Jo-1 with lung disease but lacked survival metrics. Predictive modeling for outcomes is underdeveloped.
Detection Assay Variability
Immunoprecipitation versus line blots yield discrepant MSA results (Betteridge and McHugh, 2015, 1019 citations). Hanke et al. (2009) highlighted independent markers like anti-PM/Scl needing reliable assays (447 citations). Multiplex assays require validation.
Essential Papers
Myositis‐specific autoantibodies: an important tool to support diagnosis of myositis
Zoë Betteridge, NJ McHugh · 2015 · Journal of Internal Medicine · 1.0K citations
Abstract The idiopathic inflammatory myopathies are characterized by muscle weakness, skin disease and internal organ involvement. Autoimmunity is known to have a role in myositis pathogenesis, and...
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
Lori A. Love, Richard L. Leff, D. D. Fraser et al. · 1991 · Medicine · 969 citations
The IIM are a heterogeneous group of systemic rheumatic diseases which share the common features of chronic muscle weakness and mononuclear cell infiltrates in muscle. A number of classification sc...
Idiopathic inflammatory myopathies
Ingrid E. Lundberg, Manabu Fujimoto, Jiří Vencovský et al. · 2021 · Nature Reviews Disease Primers · 596 citations
Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease
E. J. Kim, Brett M. Elicker, Fabien Maldonado et al. · 2009 · European Respiratory Journal · 577 citations
Interstitial lung disease is a common manifestation of rheumatoid arthritis; however, little is known about factors that influence its prognosis. The aim of the present study was to determine wheth...
Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease.
Robert M. Bernstein, Stephen H. Morgan, Jeffrey T. Chapman et al. · 1984 · BMJ · 549 citations
An autoantibody known as anti-Jo-1 antibody is found in 25% of patients with myositis. Its prevalence in patients with both myositis and cryptogenic fibrosing alveolitis was 68% (13 out of 19 patie...
Autoantibodies in Polymyositis and Dermatomyositis
Anna Ghirardello, Nicola Bassi, Lavinia Palma et al. · 2013 · Current Rheumatology Reports · 461 citations
Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients
Katharina Hanke, Claudia Brückner, Cornelia Dähnrich et al. · 2009 · Arthritis Research & Therapy · 447 citations
Reading Guide
Foundational Papers
Start with Love et al. (1991, 969 citations) for IIM classification integrating early MSAs, then Bernstein et al. (1984, 549 citations) for anti-Jo-1 ILD marker, and Mimori et al. (1981, 434 citations) for anti-Ku discovery.
Recent Advances
Study Mariampillai et al. (2018, 418 citations) for MSA-based subgroups and Lundberg et al. (2021, 596 citations) for updated myopathies review with MSA phenotyping.
Core Methods
Core techniques: RNA immunoprecipitation for MSA identification (Betteridge 2015), line blot assays (Ghirardello 2013), and clinical correlation via myositis panels.
How PapersFlow Helps You Research Myositis-Specific Autoantibodies
Discover & Search
Research Agent uses searchPapers('myositis-specific autoantibodies anti-Jo-1') to retrieve Betteridge and McHugh (2015, 1019 citations), then citationGraph reveals Bernstein et al. (1984) as a key predecessor, and findSimilarPapers expands to Mariampillai et al. (2018). exaSearch uncovers rare MSA overlaps from 250M+ OpenAlex papers.
Analyze & Verify
Analysis Agent applies readPaperContent on Love et al. (1991) to extract classification criteria, verifyResponse with CoVe cross-checks MSA prevalence claims against Lundberg et al. (2021), and runPythonAnalysis computes citation trends or MSA frequency stats from exported CSV. GRADE grading scores evidence strength for anti-Jo-1 lung associations.
Synthesize & Write
Synthesis Agent detects gaps in MSA prognostic studies via contradiction flagging across Ghirardello et al. (2013) and recent papers, while Writing Agent uses latexEditText for manuscript sections, latexSyncCitations to integrate 10+ references, and latexCompile for review-ready PDFs. exportMermaid visualizes MSA-clinical phenotype networks.
Use Cases
"Statistical prevalence of anti-Jo-1 in myositis with ILD from key papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas aggregation of prevalences from Bernstein 1984 and Betteridge 2015) → matplotlib prevalence plot and stats table.
"Draft LaTeX review on MSA classification systems"
Synthesis Agent → gap detection → Writing Agent → latexEditText (insert intro) → latexSyncCitations (add Love 1991, Mariampillai 2018) → latexCompile → PDF with MSA diagram via latexGenerateFigure.
"Find code for MSA detection assay analysis"
Research Agent → paperExtractUrls (from Lundberg 2021) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis on repo scripts for immunoassay data processing.
Automated Workflows
Deep Research workflow scans 50+ MSA papers via searchPapers → citationGraph → structured report with GRADE-scored summaries from Betteridge (2015). DeepScan's 7-step chain verifies anti-Jo-1 claims (Bernstein 1984) using CoVe checkpoints and runPythonAnalysis. Theorizer generates hypotheses on MSA evolution from foundational (Love 1991) to recent (Mariampillai 2018) classifications.
Frequently Asked Questions
What are myositis-specific autoantibodies?
MSAs target unique antigens like Jo-1 (histidyl-tRNA synthetase) or Mi-2 in inflammatory myopathies. Betteridge and McHugh (2015) define them as diagnostic tools present in 60-80% of cases.
What detection methods are used for MSAs?
Methods include RNA immunoprecipitation, line immunoassays, and ELISA. Ghirardello et al. (2013) compared these for polymyositis-dermatomyositis; immunoprecipitation remains gold standard.
What are key papers on MSAs?
Betteridge and McHugh (2015, 1019 citations) reviews diagnostic role; Bernstein et al. (1984, 549 citations) links anti-Jo-1 to ILD; Love et al. (1991, 969 citations) integrates into IIM classification.
What open problems exist in MSA research?
Challenges include assay standardization, cancer-MSA links (e.g., anti-TIF1-γ), and ethnic variability. Lundberg et al. (2021) calls for prospective cohorts to clarify prognostics.
Research Inflammatory Myopathies and Dermatomyositis with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Myositis-Specific Autoantibodies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers